Vaccinating livestock and poultry for the H5 series of avian influenza viruses does not have support from the entire ag sector. Friday, Zoetis announced USDA issued a conditional license for it’s killed virus-derived vaccine labeled for use in chickens.

Zoetis today announced that the U.S. Department of Agriculture (USDA), Center for Veterinary Biologics (CVB) has issued the company a conditional license for its Avian Influenza Vaccine, H5N2 Subtype,

Zoetis on Feb. 14 received a conditional license from USDA for Avian Influenza Vaccine, H5N2 Subtype, Killed Virus.

There is new hope when it comes to egg prices. A company producing a bird flu vaccine has now been granted conditional approval from the United States Department of Agriculture. While this current strain of the avian flu has been top of mind for the past few months,

A New Jersey pharmaceutical company has received a “a conditional license" for its bird flu vaccine for use in chickens. An infectious diseases expert comments.

The US Department of Agriculture (USDA) has granted conditional approval for a new bird flu vaccine for poultry.

Zoetis CEO Kristin Peck joins 'Closing Bell Overtime' to talk its Avian Flu vaccine, the impact of tariffs, and more.

Whether or not to implement a vaccination strategy against avian influenza in commercial poultry is a contentious issue in the U.S.

In the past three years, the U.S. Department of Agriculture (USDA) says about 150 million birds died across the country due to the virus. This month, the USDA granted a conditional license to Zoetis for its Avian Influenza Vaccine.